Objective: To examine the impact of balloon atrial septostomy (BAS) on cardio-respiratory status, need for prostaglandin E 1 (PGE 1 ) and postoperative outcomes in infants with transposition of great arteries (TGA).
Introduction
Transposition of great arteries (TGA) is the second most common congenital cardiac defect encountered in early infancy and the leading reason for transfer to a cardiac unit in the first 2 weeks of life. 1, 2 The preoperative management of TGA consists of prostaglandin E 1 (PGE 1 ) infusion to maintain ductal patency and balloon atrial septostomy (BAS) to enhance mixing at the atrial level. PGE 1 is effective in alleviating hypoxemia in the majority of infants with TGA. [3] [4] [5] [6] The value of BAS has been demonstrated and a significant decrease in early mortality demonstrated for severely hypoxic neonates. 3, [7] [8] [9] [10] [11] [12] BAS continues to be extensively used for widely varying indications in the era of early surgical repair. Lately, however, concerns about the 'routine' use of BAS have emerged, with some studies demonstrating an association with stroke and the recognition that the closure of the atrial septal defect may prolong the surgical repair and contribute to perioperative risk. [13] [14] [15] In addition, despite successful creation of an adequate-sized anatomic atrial septal defect in most cases, a high rate of 'failed BAS' with suboptimal increase in systemic oxygenation has been reported. 16 Apart from clinical improvement in oxygenation, another goal of the BAS procedure is discontinuation of PGE 1 . 17 The purported benefits of discontinuation of PGE 1 include elimination of associated adverse effects such as apnea and fever and according to a single study, shorter postoperative length of hospital and intensive care unit stay. 18 Whether and in what proportion of infants BAS is efficacious in this particular goal and its impact, if any, on clinical outcomes remain unclear.
Our broad objective in this study was to examine the impact of BAS on cardio-respiratory status, need for PGE 1 and postoperative clinical outcomes in infants with TGA, in the era of prompt PGE 1 administration and early surgical repair. Our specific aims were threefold: (1) to determine the effects of BAS in neonates with TGA on cardio-respiratory parameters and postprocedure requirement of PGE 1 , (2) to identify factors associated with successful BAS, defined a priori as discontinuation of PGE 1 and (3) to compare overall clinical outcomes between three groups of infants with TGA: no BAS (group 1), successful BAS (group 2) and unsuccessful BAS (group 3).
Methods
This was a retrospective chart review of consecutive patients.
Inclusion criteria
All neonates (<1-month-old) with a diagnosis of TGA admitted to Children's Hospital of Michigan Neonatal Intensive Care Unit between 1 January 2002 and 11 January 2008 identified by the neonatal intensive care unit discharge database.
Exclusion criteria
TGA associated with other major extra-cardiac congenital malformations, infants in whom a decision was made not to continue aggressive care and complex congenital cardiac defects (of which TGA was a component) who underwent surgical repair other than an arterial switch or who required PGE 1 for coexisting lesions were excluded from further analyses.
The Human Investigation Committee of Wayne State University approved the study and waiver of parental consent. Demographic, clinical and outcomes data were collected by retrospective chart review of infants who met eligibility criteria. Echocardiographic reports of all echocardiograms performed on included infants were reviewed; the initial diagnostic echocardiogram was used to evaluate size of shunts and cardiac function at presentation. The echocardiogram closest to BAS was used to collect data on 'pre-BAS' variables and echocardiograms performed within 24 h of the procedure were considered the post-BAS study. A 'successful BAS' was defined as successful discontinuation of PGE 1 anytime before surgical repair, irrespective of the number of attempts involved. For assessing the effects of BAS, clinical and ventilatory variables were assessed over a 4-h period at three points in time, (1) at presentation, (2) 24 h after BAS and (3) immediately before surgical repair. Respiratory severity scores (RSSs) and modified inotropic score were calculated using standard formulae (mean airway pressure Â fraction of inspired oxygen) and 19, 20 BAS was performed either in the catheterization laboratory, which is in close proximity to our Neonatal Intensive Care Unit or at the bedside by pediatric interventional cardiologists. During the earlier part of the study, a preoperative angiography was often performed in infants with TGA to delineate specific coronary artery anatomy in the catheterization laboratory and BAS was performed during the same procedure. At least one attempt to taper and discontinue PGE 1 after BAS was made in all cases. PGE 1 was restarted in case of significant desaturations, hypoxia or metabolic acidosis, according to the discretion of the clinical team.
Statistical analysis
Descriptive statistics was employed as appropriate (mean ± s.d., median and range for continuous variables and number and frequencies for categorical variables). Between groups comparison of mean values was by Student's t-tests and Mann-Whitney U-test for respective parametric and nonparametric datasets. w 2 test was used to compare proportions between groups. One-way analysis of variance and Kruskal-Wallis tests were used respectively for parametric and nonparametric comparisons of continuous variables among three groups. Bivariate correlation using Spearman's r was used to correlate duration of PG use and other continuous outcome variables. Binary logistic regression, with Hosmer-Lemeshow goodness of fit was used to examine the association between clinical and echocardiographic variables and 'successful BAS' as well as a favorable postoperative outcome. Level of significance was set at P-value<0.05.
Results

Patient characteristics
A total of 88 patients with a discharge diagnosis of TGA were identified from the neonatal intensive care unit database ( Figure 1 ). Of these, 28 patients were excluded (25 met the exclusion criteria, 2 patients died on the way before transfer to our hospital and 1 patient underwent BAS at the referring hospital). Table 1 describes baseline demographic and clinical characteristics of the study cohort. As expected, 70% of our cohort were males and most (n ¼ 54, 90%) were term infants. PGE 1 was initiated in 58 (96.6%) infants; the two patients who did not require PGE 1 had large ventricular septal defects (VSD) with good mixing. TGA with intact ventricular septum was diagnosed in 40 (66.6%) cases, while the remaining 20 (33.3%) had TGA with a small (7), moderate (7) or large VSD (6) . Infants who had coexisting defects such as dextrocardia or Taussig-Bing anomaly were reclassified into either TGA with intact ventricular septum or TGA with VSD for study purposes. At presentation, median (range) minimum and maximum saturations (SaO 2 ), maximum fraction of inspired oxygen (FiO 2 ) and maximum RSS were 64.5% (20 to 95), 85% (54 to 96), 60% (21 to 100) and 4.6% (1.5 to 20), respectively. During the preoperative period, 40 (66.7%) infants were mechanically ventilated. Before BAS, 17 (28.3%) infants were on pressors, all of whom were on dopamine, 7 (11.7%) on dopamine and dobutamine, 1 (1.7%) on dopamine, dobutamine and epinephrine drips and another on dopamine and epinephrine. A total of 42 (70%) infants underwent BAS at a median age of 15.5 h (1.5 to 168 h), 8.7 h (0 to 168 h) after admission. Documented indications for BAS were desaturations on pulse oximetry despite PGE 1 in 12 (28%), echocardiographic evidence of restrictive mixing in 14 (33.3%), echocardiographic restricted mixing and desaturations in 8 (19%) and 'routine' in 8 (19%) cases. The median timing for arterial switch operation was 7 days; there were two infants who underwent delayed surgical repair up to 30 days because of necrotizing enterocolitis and sepsis. Four infants developed a stroke (on ultrasound/MRI) before surgical repair and three infants died, two before surgical repair. Causes of death were 'multiple organ dysfunction syndrome' following repair in one infant, necrotizing enterocolitis, Escherichia coli bloodstream infection and pneumonia in another and sudden cardiac arrest, thought to be secondary to myocardial ischemia in the third.
Effect of balloon atrial septostomy BAS resulted in the creation of a moderate to large-sized atrial septal defect in all except one infant with a significant decrease in the proportion of infants with a small shunt at the patent foramen ovale (73.8% before and 2.4% after BAS). A moderate-sized atrial shunt was noted after BAS in 87% of procedures performed in the catheterization laboratory and 80% of bedside BAS procedures, whereas a large shunt was documented in 13 and 20%, respectively, which were not significantly different. The single infant with a persistent small shunt underwent BAS at bedside. There were no complications directly related to the procedure. BAS resulted in a significant increase in the minimum and maximum SaO 2 and drop in FiO 2 requirement 24 h after the procedure (Figure 2) . The peak RSSs, fractional shortening and ejection fraction did not significantly change after BAS. The significant improvement of oxygenation following BAS appeared sustained; minimum and maximum SaO 2 and maximum FiO 2 24 h after BAS were comparable to values just before surgical repair. Only 16 (38%) infants who underwent BAS were weaned off PGE 1 successfully (meeting our a priori definition of 'successful BAS'). Rates of successful discontinuation of PGE 1 among infants who underwent BAS in the catheterization laboratory (11/26, 42.3%) and at the bedside (5/16, 31.2%) were not significantly different. The median (range) duration at PGE 1 discontinuation was 53.5 h (0.5 to 398 h) following BAS. The initial attempt to discontinue PGE 1 was within 24 h of BAS in 18 infants and succeeded in 10 (55.5%) whereas the initial attempt was beyond 24 h in 24 infants and was successful in 6 (25%). Figure 1 Flowchart of study cohort. successful BAS. Although both groups showed improvements in minimum and maximum SaO 2 , FiO 2 requirement and RSSs, the mean FiO 2 requirement and RSSs were significantly higher after the procedure in the group of infants with 'unsuccessful' BAS. The one infant with a small shunt at patent foramen ovale even after BAS did not wean off PGE 1 .
Factors associated with successful discontinuation of PGE 1 after BAS Table 3 compares characteristics of groups of infants who underwent BAS and subsequent discontinuation of PGE 1 and 'failed' attempted discontinuation of PGE 1 . The only significant differences were that the successful BAS group had a higher proportion of males (93.8 vs 61.5%, P ¼ 0.021), TGA with VSD (50 vs 7.7%, P ¼ 0.014) and a moderate to large shunt at VSD (25.1 vs 3.8%, P ¼ 0.002). There were no differences in the shunts at patent foramen ovale, mean minimum or maximum SaO 2 , FiO 2 requirements, ventilatory support (maximal peak inspiratory Abbreviations: BAS, balloon atrial septostomy; PDA, patent ductus arteriosus; PGE 1 , prostaglandin E 1 ; PIP, peak inspiratory pressure; RSS, respiratory severity score; s.d., standard deviation; VSD, ventricular septal defects. *P ¼ 0.021. **P ¼ 0.014. ***P ¼ 0.019.
Impact of balloon atrial septostomy on outcomes in TGA G Hiremath et al pressure or RSS), fractional shortening or ejection fraction at presentation among the two groups. On binary logistic regression, using gender, type of TGA (simple vs TGA with VSD), time of BAS and time of initiation of PGE 1 as covariates, male gender and TGA with VSD tended to be associated with successful discontinuation of PGE 1 (gender odds ratio 0.13 (95% confidence interval 0.01 to 1.23, P ¼ 0.07) and TGA with VSD odds ratio 4.05 (95% confidence interval 0.88 to 18.62, P ¼ 0.07)).
Comparison of clinical outcomes of three groups of infants: no BAS, successful BAS and unsuccessful BAS: Table 4 depicts a comparison of postoperative clinical outcomes of the three groups. There were no statistically significant differences between groups, although there was a trend towards a shorter duration of ventilation in the successful BAS group. As the groups differed significantly in PGE 1 duration, as expected, we correlated duration of PGE 1 and clinical outcomes. A significant positive correlation was noted between the total duration of PGE 1 and length of hospital stay, duration of postoperative ventilation and oxygen requirement and maximal RSS after surgical repair (all P<0.05).
Discussion
Our findings reiterate the fact that BAS is effective in relieving hypoxemia, with an increase in oxygen saturations and decrease in oxygen requirement at 24 h. A nonrestrictive atrial communication is known to optimize mixing and improve systemic oxygen content and cardiac output as well as reduce left atrial pressures. A continuing need for PGE 1 17, 18 Finan's study examined the effects of time of discontinuation of PGE 1 following BAS on oxygenation and need for PGE 1 reinstitution. Early (<2 h) discontinuation was associated with rebound hypoxemia and a threefold increase in the need for reinstitution of PGE 1 . In contrast, in our cohort, despite a fairly delayed attempt at PGE 1 discontinuation (median 53 h), PGE 1 needed to be reinstituted in the majority.
To our knowledge, this is the first study to attempt to identify factors associated with successful discontinuation of PGE 1 after BAS. A shunt at the ventricular level, in addition to an adequate atrial communication appears to be a biologically plausible factor for no longer needing PGE 1 for ductal patency. There is lack of data on gender or genomic variations in therapeutic response in this population; therefore, the 'success' observed in male infants needs further validation. The reasons for the continuing need for PGE 1 in infants with TGA despite successful BAS remain unclear. One mechanism could be that PGE 1 improves pulmonary blood flow by enhancing ductal patency and by a direct pulmonary vasodilator effect. Direct pulmonary vasodilator effects of PGE 1 on pulmonary veins have been previously demonstrated, as it has an association between pulmonary hypertension and dTGA. [21] [22] [23] [24] We noted a significant positive correlation with the total duration of PG use and duration of postoperative oxygen and ventilatory requirement and length of hospital stay. Similar data have been reported in another study. 18 We speculate that the correlation between duration of PGE 1 and adverse outcomes may be related to the effect of PGs on soft-tissue edema and respiratory drive. 25, 26 The tissue edema and 'friability' might possibly result in delayed wound healing and prolonged ventilatory requirement, resulting in longer hospital stay.
Four infants had strokes confirmed by MRI, a rate in accord with recent data. We did not find a statistically significant difference in stroke rate between groups of infants who underwent BAS and those who did not, although this was probably due to insufficient power. The relationship between stroke, TGA and BAS in neonates has emerged as an intense focus of investigation. McQuillen et al. 13, 14 found that about 40% of infants with congenital heart defects had preoperative brain injury and implicated BAS as contributory to preoperative stroke in neonates with TGA. These findings were confounded by lower Apgar scores, lower arterial oxygen saturations and hemodynamic instability. Beca et al. 27 described preoperative brain injury in 30% infants with TGA, hypoplastic left heart or pulmonary atresia with a predominant pattern of white matter injury. Stroke was diagnosed in 5% and BAS did not increase the risk of preoperative brain injury. In another study, Petit et al., in a cohort of 26 infants with TGA found periventricular leucomalacia in 38%, which was not associated with BAS but with lower preoperative oxygenation and longer time to surgery. 28 The limitations of our study include its retrospective nature and the inherent associated biases. Our sample size was small, although in line with similar studies. The indications for BAS and reasons for continuing or restarting PGE 1 while generally similar varied according to individual physician practices. Despite these caveats, our data from a recent cohort are representative of current practices and outcomes and examine the impact of preoperative management modalities among neonates with TGA, a relatively under-investigated area.
